Dicerna Pharmaceuticals

Dicerna

Application Form

Our
Company Grants & Charitable Donations Application Form

Our mission

We interfere with disease

We use RNA interference, or RNAi, to create medicines that silence the genes that cause or contribute to disease. Our goal is to provide life-changing therapies to people living with rare and common diseases.

novo nordisk

Effective 28 December 2021 Dicerna Pharmaceuticals, Inc. is a wholly owned subsidiary of Novo Nordisk A/S

PRESS RELEASE
CONTINUE TO DICERNA.COM
VISIT NOVONORDISK.COM